The Valley Desk

ArticleDermatology and therapyPublished

Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Dermatology and therapy
Published
Subject terms
Safety; Pharmacokinetics; Psoriasis; Chinese Subjects; Deucravacitinib; Tyrosine Kinase 2 Inhibitor
PubMed ID
37981596
PubMed Central ID
PMC10689320
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal